Editorial

Get Permission
Rev Diabet Stud, 2004, 1(2):55-57 DOI 10.1900/RDS.2004.1.55

Will C-Peptide Substitution Make a Difference in Combating Complications in Insulin-Deficient Diabetes?

Anders A.F. Sima

Departments of Pathology and Neurology, Wayne State University, 540 E. Canfield Avenue, Detroit, MI 48201, USA, e-mail: asima@med.wayne.edu.

Abstract

n/a

Fulltext: HTML , PDF (157KB)


This article has been cited by other articles:

Zinc-activated C-peptide resistance to the type 2 diabetic erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin

Meyer JA, Subasinghe W, Sima AA, Keltner Z, Reid GE, Daleke D, Spence DM

Mol Biosyst 2009. 5:1157-1162

Rosuvastatin positively changes nerve electrophysiology in diabetic rats

Tarhzaoui K, Valensi P, Leger G, Cohen-Boulakia F, Lestrade R, Behar A

Diabetes Metab Res Rev 2009. 25(3):272-278